{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T04:05:12Z","timestamp":1772424312348,"version":"3.50.1"},"reference-count":5,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"},{"start":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T00:00:00Z","timestamp":1658880000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Encorafenib is a BRAF inhibitor increasingly used as a second-line treatment for metastatic melanoma and colorectal cancer. BRAF inhibitors have been reported to be associated with new and changing melanocytic lesions, including eruptive naevi. We describe two cases of eruptive naevi secondary to encorafenib used for the treatment of BRAF-mutant metastatic colorectal cancer.<\/jats:p>","DOI":"10.1111\/ced.15276","type":"journal-article","created":{"date-parts":[[2022,5,28]],"date-time":"2022-05-28T07:49:45Z","timestamp":1653724185000},"page":"1857-1858","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Eruptive naevi associated with encorafenib for metastatic colorectal cancer: two cases"],"prefix":"10.1093","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7532-8604","authenticated-orcid":false,"given":"Yasmin","family":"Alfallouji","sequence":"first","affiliation":[{"name":"University College London Hospital NHS Trust London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3386-8458","authenticated-orcid":false,"given":"Ashley","family":"Spencer","sequence":"additional","affiliation":[{"name":"Imperial College NHS Trust London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Calonje","sequence":"additional","affiliation":[{"name":"Guy's and St Thomas' NHS Foundation Trust London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Conal M.","family":"Perrett","sequence":"additional","affiliation":[{"name":"University College London Hospital NHS Trust London UK"},{"name":"The Devonshire Clinic London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8337-2501","authenticated-orcid":false,"given":"Richard","family":"Watchorn","sequence":"additional","affiliation":[{"name":"Imperial College NHS Trust London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Borysiewicz","sequence":"additional","affiliation":[{"name":"Imperial College NHS Trust London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8891-738X","authenticated-orcid":false,"given":"Tara","family":"Hodgkinson","sequence":"additional","affiliation":[{"name":"Imperial College NHS Trust London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harpreet","family":"Wasan","sequence":"additional","affiliation":[{"name":"Imperial College NHS Trust London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6693-7483","authenticated-orcid":false,"given":"Christopher B.","family":"Bunker","sequence":"additional","affiliation":[{"name":"University College London Hospital NHS Trust London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel U.","family":"Sidwell","sequence":"additional","affiliation":[{"name":"The Devonshire Clinic London UK"},{"name":"West Hertfordshire Hospitals NHS Trust LondonUK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,10,1]]},"reference":[{"key":"2023010808130053100_ced15276-bib-0001","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1200\/JCO.2011.41.1660","article-title":"Atypical melanocytic proliferations and new primary melanomas in patients with advanced melanoma undergoing selective BRAF inhibition","volume":"30","author":"Zimmer","year":"2012","journal-title":"J Clin Oncol"},{"key":"2023010808130053100_ced15276-bib-0002","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/CMR.0000000000000127","article-title":"Eruptive naevi in a patient treated with LGX818 for BRAF mutant metastatic melanoma","volume":"25","author":"Anforth","year":"2015","journal-title":"Melanoma Res"},{"key":"2023010808130053100_ced15276-bib-0003","doi-asserted-by":"crossref","first-page":"102","DOI":"10.4103\/0378-6323.191130","article-title":"Cutaneous toxicity of a new BRAF inhibitor, LGX818 (encorafenib)","volume":"83","author":"Pascual","year":"2017","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"2023010808130053100_ced15276-bib-0004","doi-asserted-by":"crossref","first-page":"441","DOI":"10.21873\/invivo.11793","article-title":"Eruptive melanocytic nevi secondary to encorafenib for BRAF mutant metastatic colorectal cancer","volume":"34","author":"Meneguzzo","year":"2020","journal-title":"In Vivo"},{"key":"2023010808130053100_ced15276-bib-0005","doi-asserted-by":"crossref","first-page":"100328","DOI":"10.1016\/j.esmoop.2021.100328","article-title":"Management of adverse events from the treatment of encorafenib plus cetuximab for patients with BRAF V600E-mutant metastatic colorectal cancer: insights from the BEACON CRC study","volume":"6","author":"Tabernero","year":"2021","journal-title":"ESMO Open"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ced.15276","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ced.15276","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/47\/10\/1857\/48530424\/ced1857.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/47\/10\/1857\/48530424\/ced1857.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:58:18Z","timestamp":1676386698000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/47\/10\/1857\/6966080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,1]]},"references-count":5,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10,1]]},"published-print":{"date-parts":[[2022,10,1]]}},"URL":"https:\/\/doi.org\/10.1111\/ced.15276","relation":{},"ISSN":["1365-2230","0307-6938"],"issn-type":[{"value":"1365-2230","type":"electronic"},{"value":"0307-6938","type":"print"}],"subject":[],"published-other":{"date-parts":[[2022,10,1]]},"published":{"date-parts":[[2022,10,1]]},"assertion":[{"value":"2022-05-23","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}